Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 1
2010 3
2011 3
2012 2
2013 2
2014 6
2015 7
2016 5
2017 12
2018 17
2019 13
2020 24
2021 19
2022 13
2023 17
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yuhuan zhou[Author] (14 results)?
The cancer metabolic reprogramming and immune response.
Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, Liang J, Tang Y, Su M, Luo X, Yang Y, Shi Y, Wang H, Zhou Y, Liao Q. Xia L, et al. Among authors: zhou y. Mol Cancer. 2021 Feb 5;20(1):28. doi: 10.1186/s12943-021-01316-8. Mol Cancer. 2021. PMID: 33546704 Free PMC article. Review.
Single-cell RNA sequencing in cancer research.
Zhang Y, Wang D, Peng M, Tang L, Ouyang J, Xiong F, Guo C, Tang Y, Zhou Y, Liao Q, Wu X, Wang H, Yu J, Li Y, Li X, Li G, Zeng Z, Tan Y, Xiong W. Zhang Y, et al. Among authors: zhou y. J Exp Clin Cancer Res. 2021 Mar 1;40(1):81. doi: 10.1186/s13046-021-01874-1. J Exp Clin Cancer Res. 2021. PMID: 33648534 Free PMC article. Review.
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng Z. Wei X, et al. Among authors: zhou y. Mol Cancer. 2021 Jan 4;20(1):7. doi: 10.1186/s12943-020-01288-1. Mol Cancer. 2021. PMID: 33397409 Free PMC article. Review.
Ferritinophagy: research advance and clinical significance in cancers.
Wang J, Wu N, Peng M, Oyang L, Jiang X, Peng Q, Zhou Y, He Z, Liao Q. Wang J, et al. Among authors: zhou y. Cell Death Discov. 2023 Dec 18;9(1):463. doi: 10.1038/s41420-023-01753-y. Cell Death Discov. 2023. PMID: 38110359 Free PMC article. Review.
Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc.
Zhong Y, Yang L, Xiong F, He Y, Tang Y, Shi L, Fan S, Li Z, Zhang S, Gong Z, Guo C, Liao Q, Zhou Y, Zhou M, Xiang B, Li X, Li Y, Zeng Z, Li G, Xiong W. Zhong Y, et al. Among authors: zhou y. Signal Transduct Target Ther. 2021 Jun 25;6(1):240. doi: 10.1038/s41392-021-00562-y. Signal Transduct Target Ther. 2021. PMID: 34168109 Free PMC article.
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity.
Lin J, Xia L, Oyang L, Liang J, Tan S, Wu N, Yi P, Pan Q, Rao S, Han Y, Tang Y, Su M, Luo X, Yang Y, Chen X, Yang L, Zhou Y, Liao Q. Lin J, et al. Among authors: zhou y. Oncogene. 2022 Feb;41(7):1024-1039. doi: 10.1038/s41388-021-02148-y. Epub 2022 Jan 8. Oncogene. 2022. PMID: 34997215 Free PMC article.
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.
Tan S, Yang Y, Yang W, Han Y, Huang L, Yang R, Hu Z, Tao Y, Liu L, Li Y, Oyang L, Lin J, Peng Q, Jiang X, Xu X, Xia L, Peng M, Wu N, Tang Y, Cao D, Liao Q, Zhou Y. Tan S, et al. Among authors: zhou y. J Exp Clin Cancer Res. 2023 Mar 10;42(1):59. doi: 10.1186/s13046-023-02634-z. J Exp Clin Cancer Res. 2023. PMID: 36899389 Free PMC article. Review.
Exosomes in Nasopharyngeal Carcinoma.
Zhou Y, Xia L, Lin J, Wang H, Oyang L, Tan S, Tian Y, Su M, Wang H, Cao D, Liao Q. Zhou Y, et al. J Cancer. 2018 Feb 11;9(5):767-777. doi: 10.7150/jca.22505. eCollection 2018. J Cancer. 2018. PMID: 29581754 Free PMC article. Review.
Organoids: opportunities and challenges of cancer therapy.
Jiang X, Oyang L, Peng Q, Liu Q, Xu X, Wu N, Tan S, Yang W, Han Y, Lin J, Xia L, Peng M, Tang Y, Luo X, Su M, Shi Y, Zhou Y, Liao Q. Jiang X, et al. Among authors: zhou y. Front Cell Dev Biol. 2023 Jul 27;11:1232528. doi: 10.3389/fcell.2023.1232528. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37576596 Free PMC article. Review.
138 results